Ravi Singh

8.5k citations

84 papers · 6.5k indexed · 3 hit papers · h-index 39

Impact in

Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Biomedical Engineering top 0.5%
- Graphene and Nanomaterials Applications
- Nanoplatforms for cancer theranostics

Papers in

Developmental Neuroscience 5
Biomaterials 12
- Nanoparticle-Based Drug Delivery 11

Co-authors: Kostas Kostarelos Maurizio Prato Davide Pantarotto Suzy V. Torti Alberto Bianco David McCarthy Lara Lacerda Mathieu Erhardt
Journals: Scientific Reports (3 papers)Nanomedicine (3 papers)Cancer Research (3 papers)Proceedings of the National Academy of Sciences (3 papers)Nature Communications (2 papers)
Partner nations: United States China United Kingdom

In The Last Decade

Ravi Singh

84 papers receiving 6.4k citations

Hit Papers

align trajectories log scale

Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers 2006 · 788 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2006 Proceedings of the National Academy of Sciences
2005 Journal of the American Chemical Society
2004 Angewandte Chemie International Edition

Peers

Countries citing papers authored by Ravi Singh

Since Specialization

Citations

This map shows the geographic impact of Ravi Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Singh more than expected).

Fields of papers citing papers by Ravi Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Singh. The network helps show where Ravi Singh may publish in the future.

Co-authors

The 25 scholars most cited alongside Ravi Singh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ravi Singh Line = papers co-authored together Ravi Singh links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Enhancement of Triple-Negative Breast Cancer-Specific Induction of Cell Death by Silver Nanoparticles by Combined Treatment with Proteotoxic Stress Response Inhibitors Nanomaterials ·Christina M. Snyder, B. de Mateo, Khushbu Patel, Cale D. Fahrenholtz, Monica Rohde, Richard L. Carpenter, Ravi Singh	2024	3
2	Exosomal miR-1304-3p promotes breast cancer progression in African Americans by activating cancer-associated adipocytes Nature Communications ·Dan Zhao, Kerui Wu, Sambad Sharma, Fei Xing, Shih-Ying Wu, Abhishek Tyagi, Ravindra Pramod Deshpande, Ravi Singh, Martin Wabitsch, Yin‐Yuan Mo, Kounosuke Watabe	2022	22
3	Breast cancer extracellular vesicles-derived miR-1290 activates astrocytes in the brain metastatic microenvironment via the FOXA2→CNTF axis to promote progression of brain metastases Cancer Letters ·Sherona Sirkisoon, Grace L. Wong, Noah R. Aguayo, Daniel Doheny, Dongqin Zhu, Angelina T. Regua, Austin Arrigo, Sara G. Manore, Calvin J. Wagner, Alexandra Thomas, Ravi Singh, Fei Xing, Guangxu Jin, Kounosuke Watabe, Hui‐Wen Lo	2022	38
4	Silver nanoparticles selectively treat triple‐negative breast cancer cells without affecting non‐malignant breast epithelial cells in vitro and in vivo FASEB BioAdvances ·Jessica Swanner, Cale D. Fahrenholtz, Iliana Tenvooren, Brian W. Bernish, James J. Sears, Allison Hooker, Cristina M. Furdui, Elizabeth Alli, Wencheng Li, George L. Donati, Katherine L. Cook, Pierre‐Alexandre Vidi, Ravi Singh	2019	69
5	Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients Cancer Medicine ·Gatikrushna Panigrahi, Prakash Priyadarshi Praharaj, Hiroki Kittaka, Asit Ranjan Mridha, Olen M. Black, Ravi Singh, Roger S. Mercer, Adrie van Bokhoven, Kathleen C. Torkko, Chapla Agarwal, Rajesh Agarwal, Zakaria Y. Abd Elmageed, Hariom Yadav, Santosh K. Mishra, Gagan Deep	2019	85
6	Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis Cancer Research ·Fei Xing, Yin Liu, Shih-Ying Wu, Kerui Wu, Sambad Sharma, Yin‐Yuan Mo, Jiamei Feng, Stephanie Sanders, Guangxu Jin, Ravi Singh, Pierre‐Alexandre Vidi, Abhishek Tyagi, Michael D. Chan, Jimmy Ruiz, Waldemar Debinski, Boris Pasche, Hui‐Wen Lo, Linda J. Metheny‐Barlow, Ralph B. D’Agostino, Kounosuke Watabe	2018	259
7	P-Glycoprotein-Targeted Photothermal Therapy of Drug-Resistant Cancer Cells Using Antibody-Conjugated Carbon Nanotubes ACS Applied Materials & Interfaces ·Xubin Suo, Brittany N. Eldridge, Han Zhang, Chengqiong Mao, Yuanzeng Min, Yao Sun, Ravi Singh, Xin Ming	2018	63
8	Hypoxia-induced exosome secretion promotes survival of African-American and Caucasian prostate cancer cells Scientific Reports ·Gatikrushna Panigrahi, Prakash Priyadarshi Praharaj, Taylor Peak, Jessica M. Long, Ravi Singh, Johng S. Rhim, Zakaria Y. Abd Elmageed, Gagan Deep	2018	101
9	Mitochondria-targeted Probes for Imaging Protein Sulfenylation Scientific Reports ·Reetta Holmila, Stephen A. Vance, Xiaofei Chen, Hanzhi Wu, Kirtikar Shukla, Manish S. Bharadwaj, Jade Mims, Zack Wary, Glen S. Marrs, Ravi Singh, Anthony Molina, Leslie B. Poole, S. Bruce King, Cristina M. Furdui	2018	27
10	Exosomes secreted by placental stem cells selectively inhibit growth of aggressive prostate cancer cells Biochemical and Biophysical Research Communications ·Taylor Peak, Prakash Priyadarshi Praharaj, Gatikrushna Panigrahi, Michael G. Doyle, Yixin Su, Isabel R. Schlaepfer, Ravi Singh, Donald J. Vander Griend, Julie Alickson, Ashok K. Hemal, Anthony Atala, Gagan Deep	2018	26
11	MEX3C interacts with adaptor-related protein complex 2 and involves in miR-451a exosomal sorting PLoS ONE ·Pin Lü, Huanhuan Li, Ning Li, Ravi Singh, Colin E. Bishop, Xiangxian Chen, Baisong Lu	2017	58
12	Evaluation of multiwalled carbon nanotube cytotoxicity in cultures of human brain microvascular endothelial cells grown on plastic or basement membrane Toxicology in Vitro ·Brittany N. Eldridge, Fei Xing, Cale D. Fahrenholtz, Ravi Singh	2017	15
13	Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells International Journal of Nanomedicine ·Ravi Singh, Jessica Swanner, Jade Mims, Steven A. Akman, Cristina M. Furdui, Suzy V. Torti, David Carroll	2015	106
14	The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy Biomaterials ·Andrew R. Burke, Ravi Singh, David Carroll, James C. S. Wood, Ralph B. D’Agostino, Pulickel M. Ajayan, Frank M. Torti, Suzy V. Torti	2012	172
15	Determinants of the thrombogenic potential of multiwalled carbon nanotubes Biomaterials ·Andrew R. Burke, Ravi Singh, David Carroll, John D. Owen, Nancy D. Kock, Ralph B. D’Agostino, Frank M. Torti, Suzy V. Torti	2011	58
16	Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode Breast Cancer Research and Treatment ·Robert E. Neal, Ravi Singh, Heather Hatcher, Nancy D. Kock, Suzy V. Torti, Rafael V. Davalos	2010	90
17	Topical Cyclosporine Emulsion Modulates Immune Response in Experimental Dry Eye Investigative Ophthalmology & Visual Science ·S. B. Pangelinan, Cintia S. de Paiva, Ravi Singh, K. Agusala, William J. Farley, Michael E. Stern, Stephen C. Pflugfelder	2008	3
18	Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers Proceedings of the National Academy of Sciences ·Ravi Singh, Davide Pantarotto, Lara Lacerda, Giorgia Pastorin, Cédric Klumpp, Maurizio Prato, Alberto Bianco, Kostas Kostarelos Hit paper breakdown →	2006	788
19	Augmentation of pulmonary host defense against Pseudomonas by FcγRIIA cDNA transfer to the respiratory epithelium Journal of Clinical Investigation ·Stefan Worgall, Petr Bezdicek, M.-K. Kim, Jong-Gu Park, Ravi Singh, Melpo Christofidou‐Solomidou, Alice Prince, Imre Kovesdi, Alan D. Schreiber, Ronald G. Crystal	1999	5
20	Ability of a chimeric cAMP-responsive promoter to confer pharmacologic control of CFTR cDNA expression and cAMP-mediated Cl− secretion Gene Therapy ·Motoyoshi Suzuki, Ravi Singh, RG Crystal	1997	4

About Ravi Singh

Ravi Singh is a scholar working on Developmental Neuroscience, Biomaterials, Biomedical Engineering, Cancer Research and Molecular Biology, having authored 84 papers that have together received 6.5k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (15 papers), RNA Interference and Gene Delivery (15 papers), Extracellular vesicles in disease (13 papers), Virus-based gene therapy research (12 papers), Nanoparticle-Based Drug Delivery (11 papers), Graphene and Nanomaterials Applications (8 papers), MicroRNA in disease regulation (7 papers) and Nanoparticles: synthesis and applications (7 papers). The work is most often cited by research in Biomaterials (996 citations), Biomedical Engineering (2.8k citations), Materials Chemistry (2.2k citations), Cancer Research (697 citations) and Molecular Biology (2.5k citations). Ravi Singh has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Kostas Kostarelos, Maurizio Prato, Davide Pantarotto, Suzy V. Torti, Alberto Bianco, David McCarthy, Lara Lacerda, Mathieu Erhardt, Jean‐Paul Briand and Giorgia Pastorin. Their work appears in journals such as Scientific Reports, Nanomedicine, Cancer Research, Proceedings of the National Academy of Sciences and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact